Radiation

Near Add Your Location

Sorting 6 by

Accepting patients

ACCESS

HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide (ACCESS)
  • Allogeneic Stem Cell Transplant
  • Pre-Transplant
  • Phase 2

Accepting patients

Phase I Study of Escalating Doses of 225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody Added to the Conditioning Regimen of Fludarabine, Melphalan and Organ Sparing Total Marrow and Lymphoid Irradiation (TMLI) as Conditioning for Allogeneic Hematopoietic Cell Transplantation in Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome
  • Allogeneic Stem Cell Transplant
  • Monoclonal Antibody
  • CD38
  • Phase 1

Accepting patients

UCB Transplant with Myeloablative Prep

Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases
  • Allogeneic Stem Cell Transplant
  • Phase 2

Accepting patients

Personalized Natural Killer Cell Therapy

Personalized NK Cell Therapy After Chemotherapy and Cord Blood Transplant in Treating Patients With Myelodysplastic Syndrome, Leukemia, Lymphoma or Multiple Myeloma
  • Natural Killer Cells (Allogeneic)
  • Phase 2

Accepting patients

Cytokine-Treated Veto Cells Post-Transplant

Cytokine-Treated Veto Cells in Treating Participants With Hematologic Malignancies Following Stem Cell Transplant
  • Allogeneic Stem Cell Transplant
  • Phase 1/2

Accepting patients

Myeloablative Allo Stem Cell Transplant

Myeloablative Allogeneic Hematopoietic Stem Cell Transplant With Related or Unrelated Donor for Hematological Disorders
  • Allogeneic Stem Cell Transplant
  • Phase 2